In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 51 for your search:
Cancer Type/Condition:  Skin cancer, melanoma
Stage/Subtype:  stage IV melanoma
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02649, ECOG-E1609, CDR0000692568, E1609, U10CA180820, U10CA021115, NCT01274338

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110013, 11-C-0013, NCT01218867

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2011-1165, NCI-2012-00696, NCT01590082

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2013-01320, SWOG-S1221, S1221, U10CA180888, U10CA032102, NCT01902173

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 140053, 14-C-0053, NCT02054104

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 66
Sponsor: NCI
Protocol IDs: 140110, 14-C-0110, NCT02153905

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: NCI, Other
Protocol IDs: CDR0000369699, DFCI-03123, NCT00085397

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000598300, E2607, ECOG-E2607, NCT00700882

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 10-001212, 08-02-020, NCT00910650

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000654465, NCCTG-N0879, N0879, NCT00976573

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 16
Sponsor: NCI
Protocol IDs: NCI-2011-02498, CHNMC-PHII-107, CDR0000690654, PhII-107, 8628, P30CA033572, N01CM62209, N01CM00038, NCT01258855

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02580, UCCRC-10-324-B, CDR0000696233, 10-324-B, 8445, N01CM00071, P30CA014599, NCT01307618

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: VICC MEL 1036, NCI-2010-02322, R01FD003522, NCT01316692

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MC1076, NCI-2011-00449, 10-008497, NCT01328535

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 110260, 11-C-0260, NCT01468818

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 197811, NCI-2011-03037, NCT01533948

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 90
Sponsor: NCI, Other
Protocol IDs: VICC MEL 1263, NCI-2012-01699, NCT01701037

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01932, CDR0000741878, ECOG-E3611, E3611, U10CA180820, U10CA021115, NCT01708941

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2643.00, NCI-2013-00486, P30CA015704, NCT01807182

20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130105, 13-C-0105, NCT01827384

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: 12-048, R01CA169118, UPCI 12-048, NCT01876212

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RU261206I, NCI-2013-01112, ACCRU RU261206I, P30CA015083, NCT01879306

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-01732, ECOG-E3612, E3612, U10CA021115, NCT01950390

24.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CITN-04, NCI-2013-01605, U01CA154967, NCT01961115

25.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 66
Sponsor: NCI
Protocol IDs: 140022, 14-C-0022, NCT01993719
1    
New Search